Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9187798 | 1.00 | MAPK1 (0.36) | MAPK1HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL9188490 | 1.00 | MAPK1 (0.36) | MAPK1HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL118256 | 0.83 | MEN1 (0.36) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL21402635 | 0.83 | MEN1 (0.36) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL9191326 | 0.83 | MEN1 (0.36) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL3912889 | 0.83 | MEN1 (0.36) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL19924608 | 0.83 | MEN1 (0.36) | HTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL1826286 | 0.83 | MEN1 (0.31) | HTTMEN1KMT2A | |
| SCHEMBL14646344 | 0.78 | MAPK1 (0.36) | MAPK1HTTMEN1KMT2A | |
| SCHEMBL9186431 | 0.78 | MEN1 (0.33) | HTTMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4217937-A | — | — | None | — | — | JP | disclosed |
| EP-2799417-B1 | METHOD OF PRODUCING 1-(2-t-BUTYL CYCLOHEXYLOXY)-2-ALKANOL | KAO CORP (JP) | 2017-06-07 | — | — | EP | disclosed |
| CN-104024198-B | The manufacture method of 1-(2-tert-butylcyclohexoxy)-2-alkanol | 花王株式会社 | 2016-08-17 | — | — | CN | disclosed |
| US-8927777-B2 | Method of producing 1-(2-t-butyl cyclohexyloxy)-2-alkanol | KAO CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-20140350306-A1 | METHOD OF PRODUCING 1-(2-t-BUTYL CYCLOHEXYLOXY)-2-ALKANOL | KAO CORPORATION (JP) | 2014-11-27 | — | — | US | disclosed |
| EP-2799417-A1 | METHOD OF PRODUCING 1-(2-t-BUTYL CYCLOHEXYLOXY)-2-ALKANOL | Kao Corporation (JP) | 2014-11-05 | — | — | EP | disclosed |
| CN-104024198-A | Method of producing 1-(2-t-butyl cyclohexyloxy)-2-alkanol | KAO CORP | 2014-09-03 | — | — | CN | disclosed |
| EP-0616994-B1 | Process for producing ether alcohols by hydrogenolysis of cyclic ketal | KAO CORP (JP) | 1998-12-30 | — | — | EP | disclosed |
| CN-1034277-C | alpha-(alkylcyclohexyloxy)-beta-alkanols and perfume compositions containing same | KAO CORP (JP) | 1997-03-19 | — | — | CN | disclosed |
| EP-0467290-B1 | Alpha-(alkylcyclohexyloxy)-beta-alkanols and perfume compositions containing the same | KAO CORP (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-5446208-A | Process for producing ether alcohols by hydrogenolysis of cyclic ketal | KAO CORPORATION (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0616994-A2 | Process for producing ether alcohols by hydrogenolysis of cyclic ketal | KAO CORPORATION (JP) | 1994-09-28 | — | — | EP | disclosed |
| US-5194423-A | ALPHA-(ALKYLCYCLOHEXYLOXY)-BETA-ALKANOLS AND PERFUME COMPOSITIONS CONTAINING THE SAME | KAO CORPORATION (JP) | 1993-03-16 | — | — | US | disclosed |
| JP-H04217937-A | ALPHA-(ALKYLCYCLOHEXYLOXY)-BETA-ALKANOLS AND PERFUME COMPOSITION CONTAINING THE SAME ALKANOLS | KAO CORP | 1992-08-07 | — | — | JP | disclosed |
| EP-0467290-A2 | Alpha-(alkylcyclohexyloxy)-beta-alkanols and perfume compositions containing the same | Kao Corporation (JP) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350306-A1 | METHOD OF PRODUCING 1-(2-t-BUTYL CYCLOHEXYLOXY)-2-ALKANOL | TRPA1, TPSD1, TPSB2 | MAPK1 1829/4885HTT 2808/4885MEN1 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.